Artificial Biofarma Vaccines Used in 136 Countries
By : Hariyanto And Aldo Bella Putra | Monday, January 15 2018 - 20:00 IWST

Forum Merdeka Barat 9 (FMB9) "Imunisasi, Difteri, dan Gerakan Antivaksin
INDUSTRY.co.id - Jakarta - In the Independent Merdeka Barat Forum 9 (FMB9) titled "Immunization, Diphtheria and Antivaxin Movement" President Director of PT Biofarma Juliman said 136 countries have used the vaccine from PT Biofarma.
"Biofarma is the only vaccine producer in Indonesia up to now, we are implementing high quality, our products have been approved by WHO (World Health Organization)," said Juliman at the Ministry of Communication and Informatics (Kemkominfo), Jakarta, Friday (12/1) / 2018) then.
Nevertheless, Juliman said, PT Biofarma does not prioritize vaccine exports if it is in the country needier, as it is now where the Government is serious in dealing with Extraordinary Events (Disease Outbreaks) associated with Diphtheria.
"We Biofarma does not put exports in. We instead delay (export) to UNICEF and bilaterally to provide vaccines domestically, as our needs increase we add working days, from five days to seven working days, specifically to provide vaccines for domestic, "said Juliman.
Juliman confirmed, before the vaccine produced PT Biofarma sold, will be tested first by the Food and Drug Supervisory Agency (BPOM). If you have not received a certificate from BPOM, then the vaccine cannot be sold.
Therefore, he asserted that PT Biofarma production vaccine is good quality and safe for society. "If you cannot get a certificate from BPOM, vaccines cannot be sold," said Juliman.
Read Also
President Jokowi Signs Presidential Regulation on the Use of Cigarette…
Bank BRI-Siloam Hospitals Strengthens Banking Services and Health…
Heart Disease and Cancer Predicted to Dominate by 2030
Investment of IDR 450 Billion, Omni Group Begins to Operate the 4th…
Community poverty in Konawe Selatan Sultra is still high
Today's Industry

Rabu, 13 Januari 2021 - 18:40 WIB
Synopsys Recognised as a Leader in Static Application Security Testing by Independent Research Firm
Synopsys receives highest score among 12 SAST providers in current offering category.

Rabu, 13 Januari 2021 - 16:00 WIB
ZASCHE Handling Rolls Out New Range of Electric Balancers
the E-Balancer is a versatile tool suited for a broad range of heavy-duty industrial applications.

Rabu, 13 Januari 2021 - 15:40 WIB
What is the Cost of Poor Software Quality in the U.S.?
And if you doubt its credibility, or that it applies to software, check out the latest report from the Consortium for Information & Software Quality (CISQ), in partnership with Synopsys, “The…

Jumat, 08 Januari 2021 - 17:35 WIB
DevSecOps: The good, the bad, and the ugly
DevSecOps is the practice of integrating security into every stage of the DevOps pipeline.

Selasa, 29 Desember 2020 - 16:25 WIB
Universal Robots Reaches Industry Milestone with 50,000 Collaborative Robots Sold
Cobot market pioneer Universal Robots (UR) solidified its frontrunner position today by selling the 50,000th UR cobot, which was purchased by a German manufacturer to enable higher productivity…
News Comment